2-hydroxy-3,5-dimethoxybenzaldehyde | 65162-29-0

• 物质功能分类: 有机原料 - 醛类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 2-hydroxy-3,5-dimethoxybenzaldehyde
• 英文别名: 3,5-Dimethoxy-2-hydroxybenzaldehyde；3,5-dimethoxysalicylaldehyde
• CAS: 65162-29-0
• 化学式: C₉H₁₀O₄
• mdl: MFCD06740708
• 分子量: 182.176
• InChiKey: RZKNKVRCIXKLBQ-UHFFFAOYSA-N

物化性质

• 熔点：
  129.5-130.5 °C(Solv: methanol (67-56-1))
• 沸点：
  304.7±37.0 °C(Predicted)
• 密度：
  1.234±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-hydroxy-3,5-dimethoxybenzaldehyde 在 氢碘酸 、 乙酸酐 、 溶剂黄146 、 N,N'-二环己基碳二亚胺 作用下， 以 二甲基亚砜 为溶剂， 反应 15.0h， 生成 6,8-dihydroxy-3-(3,5-dihydroxyphenyl)coumarin
  参考文献：
  名称：

  Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin–resveratrol hybrids

  摘要：

  We have synthesized the coumarin-resveratrol hybrid 4 and its dimethoxy derivative 3 by a very direct synthetic route involving a Pechmann procedure. Compound 4 has also been synthesized by an alternative route (Perkin), which also allowed the synthesis of compounds 9-13. In addition, we have evaluated the potential vasorelaxant activity of the new compounds in endothelium-containing rat aorta rings pre-contracted with noradrenaline, as well as the inhibitory effects on platelet aggregation induced by thrombin in washed human platelets. The compounds reported here relaxed vascular smooth muscle and inhibited platelet aggregation with a profile similar to that of trans-resveratrol (t-RESV) and, in some cases, showed activity higher than that of the natural compound. This is the case for compound 13, which has a vasorelaxant activity that is twice as high as that of t-resveratrol and a platelet antiaggregant activity that is six times higher. These results suggest that these novel compounds may have potential as structural templates for the design and subsequent development of new vasodilatory and platelet antiaggregatory drugs. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.10.013
• 作为产物：
  描述：

  3,5-二甲氧基苯甲醛 在 水 、 碳酸氢钠 作用下， 以 甲醇 为溶剂， 生成 2-hydroxy-3,5-dimethoxybenzaldehyde
  参考文献：
  名称：

  通过反向回弹机制无金属氧化芳族碳氢键

  摘要：

  碳氢 (C-H) 键氧化方法在合成有机化学中具有重要作用，可提供最终目标分子所需的功能或促进后续化学转化。已经描述了几种氧化脂肪族 C-H 键的方法，大大简化了复杂分子的合成。然而，在温和条件下选择性氧化芳族 C-H 键，尤其是在具有不同官能团的取代芳烃的情况下，仍然是一个挑战。芳烃的直接羟基化最初是通过使用强布朗斯台德或路易斯酸与超化学计量当量的氧化剂介导亲电芳香取代反应来实现的，这显着限制了反应范围。由于这些反应的产物比起始材料更具反应性，因此过度氧化通常是一个竞争过程。已经开发了过渡金属催化芳烃的 C-H 氧化，有或没有导向基团，改进了酸介导的过程；但是，需要贵金属。在这里，我们证明过氧化邻苯二甲酰作为选择性氧化剂在温和条件下将芳烃转化为酚类。尽管反应通过自由基机制进行，但芳香族 C-H 键优先于活化的 -H 键被选择性氧化。值得注意的是，大量的官能团与该反应相容，因此该方法非常适合

  DOI：

  10.1038/nature12284

文献信息

• [EN] TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS<br/>[FR] TRAITEMENT OU PROPHYLAXIE D'ÉTATS PROLIFÉRATIFS
  申请人：UNIV DUNDEE

  公开号：WO2010125350A1

  公开（公告）日：2010-11-04

  The invention relates to novel compounds for use in the treatment or prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express cytochrome P450 1B1 (CYP1B1) and allelic variants thereof. The invention also provides pharmaceutical compositions comprising one or more such compounds for use in medical therapy, for example in the treatment of prophylaxis of cancers or other proliferative conditions, as well as methods for treating cancers or other conditions in human or non-human animal patients. The invention also provides methods for identifying novel compounds for use in the treatment of prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express CYP1 B1 and allelic variants thereof. The invention also provides a method for determining the efficacy of a compound of the invention in treating cancer.

  该发明涉及用于治疗或预防癌症和其他增殖性疾病的新化合物，例如这些疾病的特征是细胞表达细胞色素P450 1B1（CYP1B1）及其等位基因变体。该发明还提供包含一种或多种此类化合物的药物组合物，用于医学治疗，例如用于治疗或预防癌症或其他增殖性疾病，以及用于治疗人类或非人类动物患者的癌症或其他疾病的方法。该发明还提供用于识别用于治疗或预防癌症和其他增殖性疾病的新化合物的方法，例如这些疾病的特征是细胞表达CYP1B1及其等位基因变体。该发明还提供一种用于确定该发明中化合物治疗癌症的疗效的方法。
• Iron-catalyzed arene C−H hydroxylation
  作者：Lu Cheng、Huihui Wang、Hengrui Cai、Jie Zhang、Xu Gong、Wei Han

  DOI：10.1126/science.abj0731

  日期：2021.10

  selective catalytic hydroxylation of arenes remains an ongoing research challenge because of the relative inertness of aryl carbon-hydrogen bonds, the higher reactivity of the phenolic products leading to over-oxidized by-products, and the frequently insufficient regioselectivity. We report that iron coordinated by a bioinspired l-cystine–derived ligand can catalyze undirected arene carbon-hydrogen hydroxylation

  由于芳基碳氢键的相对惰性、酚类产物的较高反应性导致过度氧化的副产物以及经常不足的区域选择性，芳烃的可持续、非定向和选择性催化羟基化仍然是一项持续的研究挑战。我们报告说，铁由受生物启发的l-胱氨酸衍生的配体可以催化非定向芳烃碳氢羟基化，过氧化氢作为末端氧化剂。该反应以其广泛的底物范围、出色的选择性和良好的产率而著称，并且表现出与氧化敏感官能团的相容性，如醇、多酚、醛，甚至硼酸。该方法非常适合通过多重碳氢羟基化合成多酚，以及天然产物和药物分子的后期功能化。
• A General and Unexpected Synthesis of 2-(2-Chloro-2-nitroethenyl)phenols
  作者：Daniel Dauzonne、René Royer

  DOI：10.1055/s-1987-28156

  日期：——

  A convenient preparation of the previously unknown title compounds from 2-hydroxybenzaldehydes and bromonitromethane is described.

  描述了一种简便制备先前未知标题化合物的方法，该方法涉及2-羟基苯甲醛与溴硝甲烷的反应。
• Synthesis, antiepileptic effects, and structure-activity relationships of α-asarone derivatives: In vitro and in vivo neuroprotective effect of selected derivatives
  作者：Jian Zhang、Keman Mu、Peng Yang、Xinqian Feng、Di Zhang、Xiangyu Fan、Qiantao Wang、Shengjun Mao

  DOI：10.1016/j.bioorg.2021.105179

  日期：2021.10

  moiety, the optimal activity was reached with either an allyl or a 1-butenyl group in conjugation with the benzene ring. The compounds 5 and 19 exerted better neuroprotective effects against epilepsy in vitro (cell) and in vivo (mouse) models. This study provides valuable data for further exploration and application of these compounds as potential anti-seizure medicines.

  在本研究中，我们使用 PTZ 诱导的癫痫模型比较了 α-细辛脑衍生物的抗癫痫作用，以探索其结构-活性关系。我们的研究表明，苯环 3,4,5-位上的供电子甲氧基可增加抗癫痫效力，但其他基团放置在不同位置会降低活性。此外，在烯丙基部分中，烯丙基或1-丁烯基与苯环共轭时可达到最佳活性。化合物5和19对体外（细胞）和体内（小鼠）模型的癫痫表现出更好的神经保护作用。该研究为进一步探索和应用这些化合物作为潜在的抗癫痫药物提供了有价值的数据。
• Three-Component Coupling Strategy for Expeditious Synthesis of 4-Aminobenzoxazinones on Mineral Support
  作者：Lal Dhar Yadav、Ritu Kapoor

  DOI：10.1055/s-2005-921921

  日期：——

  Novel montmorillonite K-10 clay supported three-component reactions of substituted salicylaldehydes, N-substituted ureas/carbamates and ammonium acetate or an amine expeditiously yield 3,4-dihydro-4-amino-2H-benz[e]-1,3-oxazin-2-ones via cycloisomerization of intermediate aldimines under solvent-free microwave irradiation in a one-pot procedure.

  新型蒙脱石 K-10 粘土支持取代水杨醛、N-取代脲/氨基甲酸酯和乙酸铵或胺的三组分反应，可迅速生成 3,4-二氢-4-氨基-2H-苯 [e]-1,3-在一锅法中，在无溶剂微波辐射下通过中间体醛亚胺的环异构化来制备恶嗪-2-酮。